#news #biotech BTI files for $69M IPO to run trials in Alzheimer’s and cancer

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: BTI files for $69M IPO to run trials in Alzheimer’s and cancer .BioXcel Therapeutics (BTI) has filed to raise $69 million through a Nasdaq IPO. BTI will spend the cash on phase 2 trials of a once-failed cancer asset and an old drug repurposed for use in Alzheimer’s and schizophrenia.

from FierceBiotech: Biotech http://ift.tt/2G8w6Dm